Postsystolic strain index is associated with delayed diastolic lengthening and diastolic dysfunction of the left ventricle in untreated hypertension

Journal of Hypertension

Volumn 30, Issue 4, 2012, Pages 787-793

  Tsai, Wei Chuan ^a   Liu, Yen Wen ^a   Chen, Ju Yi ^a   Huang, Yao Yi ^a   Shih, Jhih Yuan ^b   Tsai, Liang Miin ^a   Chen, Jyh Hong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Tainan Hospital Sin Hua Branch   (Taiwan)

Author keywords

diastolic dysfunction; echocardiography; hypertensive heart disease

Indexed keywords

PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; HYPERTENSION; MALE; MITRAL VALVE; POSTSYSTOLIC STRAIN INDEX; PRIORITY JOURNAL; RELAXATION TIME; SYSTOLIC BLOOD PRESSURE;

EID: 84862776649     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834f6b2b     Document Type: Article

References (32)

1. Ishii K, Suyama T, Imai M, Maenaka M, Yamanaka A, Makino Y, et al. Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention. Clinical significance of postischemic diastolic stunning. J Am Coll Cardiol 2009; 54:1589-1597.
2. Voigt JU, Lindenmeier G, Exner B, Regenfus M, Werner D, Reulbach U, et al. Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium. J Am Soc Echocardiogr 2003; 16:415-423. (Pubitemid 36570083)
3. Nakai H, Takeuchi M, Nishikage T, Lang RM, Otsuji Y. Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 2009; 10:926-932.
4. Carlhäll C, Wranne B, Jurkevicius R. Is left ventricular postsystolic longaxis shortening a marker for severity of hypertensive heart disease? Am J Cardiol 2003; 91:1490-1493. (Pubitemid 36694733)
5. Adebayo AK, Oladapo OO, Adebiyi AA, Ogunleye OO, Ogah OS, Ojji DB, et al. Changes in left atrial dimension and function and left ventricular geometry in newly diagnosed untreated hypertensive subjects. J Cardiovasc Med 2008; 9:561-569. (Pubitemid 351677695)
6. Eshoo S, Ross DL, Thomas L. Impact of mild hypertension on left atrial size and function. Circ Cardiovasc Imaging 2009; 2:93-99.
7. Urheim S, Edvardsen T, Steine K, Skulstad H, Lyseggen E, Rodevand O, Smiseth OA. Postsystolic shortening of ischemic myocardium: a mechanism of abnormal intraventricular filling. Am J Physiol Heart Circ Physiol 2003; 284:H2343-H2350. (Pubitemid 36622450)
8. Little WC, Oh JK. Echocardiographic evaluation of diastolic function can be used to guide clinical care. Circulation 2009; 120:802-809.
9. Liu YW, Tsai WC, Su CT, Lin CC, Chen JH. Evidence of left ventricular systolic dysfunction detected by automatic function imaging in patients with heart failure and preserve left ventricular ejection fraction. J Cardiac Fail 2009; 15:782-789.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjugation with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
11. Hsu CH, Tsai WC, Tsai LM, Lin CC, Chen JY, Huang YY, et al. The effects of left ventricular hypertrophy on the respiratory changes in transmitral Doppler flow patterns of hypertension patients. Clin Physiol Funct Imaging 2005; 25:327-331.
12. Tsai WC, Tsai LM, Teng JK, Li YH, Lin LJ, Chen JH. Prognostic value of Doppler-derived mitral deceleration time in postinfarction patients with left ventricular ejection fraction of 35% or more. J Formos Med Assoc 1999; 98:70-72.
13. Benedetto U, Melina G, Roscitano A, Ciavarella GM, Tonelli E, Sinatra R. Clinical utility of tissue Doppler imaging in prediction of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2007; 83:83-88. (Pubitemid 44917905)
14. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10:165-193.
15. Belghiti H, Brette S, Lafitte S, Reant P, Picard F, Serri K, et al. Automatic function imaging: a new operator-independent strain method for assessing left ventricular function. Arch Cardiovasc Dis 2008; 101: 163-169. (Pubitemid 351739260)
16. López B, González A, Varo N, Laviades C, Querejeta R, Díez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38:1222-1226. (Pubitemid 34252835)
17. Tsai WC, Lin CC, Chen JY, Huang YY, Lee CH, Li WT, et al. Association of adiponectin with procollagen type I carboxyterminal propeptide in nondiabetic essential hypertension. Blood Press 2008; 17:233-238.
18. Rivas-Gotz C, Khoury DS, Manolios M, Rao L, Kopelen HA, Nagueh SF. Time interval between onset of mitral inflow and onset of early diastolic velocity by tissue Doppler: a novel index of left ventricular relaxation. J Am Coll Cardiol 2003; 42:1463-1470. (Pubitemid 37267291)
19. Min PK, Ha JW, Jung JH, Choi EY, Choi D, Rim SJ, et al. Incremental value of measuring the time difference between onset of mitral inflow and onset of early diastolic mitral annulus velocity for evaluation of left ventricular diastolic pressures in patients with normal systolic function and an indeterminate E/E'. Am J Cardiol 2007; 100:326-330. (Pubitemid 47042001)
20. Diwan A, McCulloch M, Lawrie GM, Reardon MJ, Nagueh SF. Doppler estimation of left ventricular filling pressures in patients with mitral valve disease. Circulation 2005; 111:3281-3289. (Pubitemid 40875001)
21. López B, González A, Querejeta R, Díez J. The use of collagen-derived serum peptides for clinical assessment of hypertensive heart disease. J Hypertens 2005; 23:1445-1451. (Pubitemid 41104811)
22. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007; 115:888-895. (Pubitemid 46294729)
23. Müller-Brunotte R, Kahan T, López B, Edner M, González A, Díez J, Malmqvist K. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). J Hypertens 2007; 25:1958-1966. (Pubitemid 47356638)
24. Plaksej R, Kosmala W, Frantz S, Herrmann S, Niemann M, Störk S, et al. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure. J Hypertens 2009; 27:2483-2491.
25. Díez J, López B, González A, Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 2001; 16:328-335.
26. Youn HJ, Ihm SH, Lee JM, Park CS, Cho EJ, Jung HO, et al. Relation between flow reserve capacity of penetrating intramyocardial coronary arteries and myocardial fibrosis in hypertension: study using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2006; 19:373-378.
27. Díez J, Laviades C, Mayor G, Gil MJ, Montreal I. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alteration. Circulation 1995; 91:1450-1456.
28. Boles U, Almuntaser I, Brown A, Murphy RRT, Mahmud A, Feely J. Ventricular activation time as a marker for diastolic dysfunction in early hypertension. Am J Hypertens 2010; 23:781-785.
29. Haugaa KH, Edvardsen T, Leren TP, Gran JM, Smiseth OA, Amlie JP. Left ventricular dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome. Eur Heart J 2009; 30:330-337.
30. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008; 52:1574-1580.
31. Ho CY, López B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010; 363:552-563.
32. McNulty M, Mahmud A, Spiers P, Feely J. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects. J Hum Hypertens 2006; 20:867-873. (Pubitemid 44614069)